相关实验视频
Updated: May 28, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.6K
在妊娠糖尿病中,葡萄糖变化和胰岛素参数之间的关联在妊娠24周后被诊断为妊娠糖尿病
Yoshifumi Kasuga1, Kaoru Kajikawa1, Naotsugu Ishikawa1
1Department of Obstetrics and Gynecology, Keio University School of Medicine, 5 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Nutrients
|February 13, 2025
概括
晚期妊娠糖尿病 (GDM) 中的葡萄糖变化 (GV) 可能反映胰岛素分泌和敏感性. 这一发现表明,GV可能会影响GDM管理中的胰岛素参数.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 产科 产科 产科 产科 产科
背景情况:
- 葡萄糖变异性 (GV) 与不良周产期结局有关.
- 在妊娠糖尿病 (GDM) 中GV的作用需要澄清.
研究的目的:
- 调查晚期GDM的日本女性GV和胰岛素参数之间的关联.
- 探索GV作为GDM管理中的标记物的潜力.
主要方法:
- 一项针对280名被诊断患有晚期GDM的日本妇女的研究.
- 使用75克口服葡萄糖耐受性测试 (OGTT) 计算GV,评估最初的增加和随后的减少.
- 对与血葡萄糖水平和胰岛素指数相关性的分析.
主要成果:
- 最初的GV增加与1小时和2小时的血葡萄糖有正相关,但与禁食葡萄糖,胰岛素生成指数 (IGI) 和胰岛素抵抗有负相关.
- 随后的GV下降与1小时的葡萄糖正相关,但与2小时的葡萄糖,IGI和胰岛素敏感性负相关.
- 在GV成分和胰岛素分泌敏感度指数-2.0之间没有发现任何关联.
结论:
- 最初的GV增加可能表明胰岛素分泌,而随后的减少可能反映了晚期GDM中的胰岛素敏感性.
- 在GDM患者中,GV可能会影响各种胰岛素参数.
- 需要进一步的研究来确定GV在GDM管理中的实用性.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Pathophysiology of Diabetes
848
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
848
Diabetes: Symptoms, Diagnosis, and Complications
499
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
499
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Dipeptidyl Peptidase 4 Inhibitors
164
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
164
Glucose Transporters
22.4K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.4K

